These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37551117)

  • 1. An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers.
    Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
    Technol Cancer Res Treat; 2023; 22():15330338231180785. PubMed ID: 37551117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Systemic Inflammatory Markers Can Improve Survival Prediction of Patients with Diffuse Large B-Cell Lymphoma: Model Development and Evaluation].
    Liu YJ; Sheng L; Zhou JF; Hua HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1136-1145. PubMed ID: 39192410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
    Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
    Cancer Manag Res; 2023; 15():651-666. PubMed ID: 37465083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China.
    Li X; Xu Q; Gao C; Yang Z; Li J; Sun A; Wang Y; Lei H
    Ann Hematol; 2023 Dec; 102(12):3465-3475. PubMed ID: 37615680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma.
    Wang Z; Bao Y; Xu Z; Sun Y; Yan X; Sheng L; Ouyang G
    J Inflamm Res; 2024; 17():1-13. PubMed ID: 38193043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
    Chen H; Zhong Q; Zhou Y; Qin Y; Yang J; Liu P; He X; Zhou S; Zhang C; Gui L; Yang S; Zhou L; Shi Y
    BMC Cancer; 2022 May; 22(1):583. PubMed ID: 35624433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a [
    Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
    Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.
    Yan J; Yuan W; Zhang J; Li L; Zhang L; Zhang X; Zhang M
    Front Endocrinol (Lausanne); 2022; 13():846357. PubMed ID: 35498426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
    Cai J; Tian X; Ma S; Zhong L; Li W; Wang L; Guo L; Li Z; Wu Y; Zhong G; Huang H; Xia Z; Xia Y; Liu P; Su N; Fang Y; Zhang Y; Cai Q
    Br J Cancer; 2021 Aug; 125(3):402-412. PubMed ID: 34012033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new prognostic model using the NCCN-IPI and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma.
    Go SI; Park S; Kim JH; Kim HR; Kim M; Moon K; Seo J; Lee GW
    Tumori; 2018 Aug; 104(4):292-299. PubMed ID: 29737944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram based on the systemic immune-inflammation index for predicting the prognosis of diffuse large B-cell lymphoma.
    Wu J; Zhu H; Zhang Q; Sun Y; He X; Liao J; Liu Y; Huang L
    Asia Pac J Clin Oncol; 2023 Apr; 19(2):e138-e148. PubMed ID: 35754170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection].
    Su J; Wang X; Sun Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):120-130. PubMed ID: 38318906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram prognostic model for diffuse large B-cell lymphoma based on SUVmax and GNRI in elderly patients.
    Li M; Lu H; Fan J; Dai M; Su C
    EJHaem; 2023 Nov; 4(4):1030-1041. PubMed ID: 38024603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma.
    Wan M; Zhang W; Huang H; Fang X; Chen Y; Tian Y; Yao Y; Weng H; Chen Z; Yu L; Tian Y; Huang H; Li X; Hong H; Lin T
    Clin Exp Med; 2024 Mar; 24(1):64. PubMed ID: 38554186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy.
    Isaksen KT; Galleberg R; Mastroianni MA; Rinde M; Rusten LS; Barzenje D; Ramslien F; Fluge O; Slaaen M; Meyer P; Liestol K; Smeland EB; Lingjarde OC; Holte H; Brodtkorb M
    Haematologica; 2023 Sep; 108(9):2454-2466. PubMed ID: 36861406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison and exploration of the prognostic value of the advanced lung cancer inflammation index, prognostic nutritional index, and systemic immune-inflammation index in newly diagnosed diffuse large B-cell lymphoma.
    Liu T; Ye F; Li Y; Liu A
    Ann Palliat Med; 2021 Sep; 10(9):9650-9659. PubMed ID: 34628890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma.
    Zhong H; Chen J; Cheng S; Chen S; Shen R; Shi Q; Xu P; Huang H; Zhang M; Wang L; Wu D; Zhao W
    EBioMedicine; 2019 Mar; 41():167-174. PubMed ID: 30827933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
    Zhong Q; Chen H; Chen D; Qin Y; He X; Yang Y; Yang J; Liu P; Zhou S; Yang S; Zhou Y; Tang L; Chen C; Shi Y
    Ann Hematol; 2024 Jan; 103(1):211-226. PubMed ID: 37861735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.